Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-03-15FDA Approved: MATZIM LA — Original Application (Actavis Pharma, Inc.)
FDA approved MATZIM LA, a diltiazem hydrochloride extended-release tablet, under Actavis Pharma's original ANDA.
-
CLINICAL_TRIALS trial_result · 2010-03-08Clinical Trial Update: Warfarin Patient Self-Monitoring [NA]
The document reports that a trial studying warfarin patient self-monitoring in atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) [Phase 3]
Phase 3 clinical trial update examining the electrophysiological effects of irbesartan in patients with paroxysmal atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm [Phase 3]
A Phase 3 trial evaluating dronedarone for maintaining sinus rhythm in patients with atrial fibrillation or atrial flutter has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) [Phase 3]
Phase 3 EURIDIS trial evaluating dronedarone for maintenance of sinus rhythm in patients with atrial fibrillation or atrial flutter has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2010-02-05FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) from Advanz Pharma (US) Corp., resulting in labeling changes for the produ…
-
FDA approval · 2010-02-05FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Lanoxin (digoxin) from Covis Pharma US, Inc., resulting in updates to the product labeling under…
-
FDA approval · 2010-02-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, approving the supplemental filing f…
-
FDA approval · 2010-02-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS research · 2010-02-02Clinical Trial Update: Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation [Phase 2, Phase 3]
This document provides an update on a Phase 2/3 trial comparing ATI-5923, a novel vitamin K antagonist, with warfarin for patients requiring…
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation [Phase 2]
Phase 2 trial evaluating K201 Injection for restoration of sinus rhythm in atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor
A completed clinical trial evaluated home monitoring of atrial fibrillation using a Microlife blood pressure monitor.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Tikosyn (dofetilide) — Pfizer Limited
Tikosyn (dofetilide) has been withdrawn in the EU by Pfizer Limited, with the medicinal product no longer authorized for use.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation [Phase 3]
Phase 3 results for dronedarone (Multaq) in preventing hospitalization or death in patients with atrial fibrillation or atrial flutter were …
-
FDA approval · 2009-12-16FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride filed by Wilshire Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation [Phase 3]
A Phase III superiority trial comparing vernakalant with amiodarone for recent-onset atrial fibrillation has completed.
-
FDA approval · 2009-12-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for verapamil hydrochloride by Mylan Pharmaceuticals Inc., enabling the generic version to be market…
-
CLINICAL_TRIALS research · 2009-12-02Clinical Trial Update: Testing Strategies to Improving Warfarin Adherence [NA]
A completed clinical trial update describing strategies to improve adherence to warfarin therapy. The study involved patients with atrial fi…
-
FDA approval · 2009-12-01FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) by Upsher-Smith Laboratories, LLC, indicating a labeling or …
-
CLINICAL_TRIALS trial_result · 2009-12-01Clinical Trial Update: Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
A completed trial from Creighton University evaluated whether inflammatory markers predict cardioversion success in atrial fibrillation. The…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients [Phase 2]
Phase 2 clinical trial update reporting results related to prothrombin time excursions outside the therapeutic range in otherwise stable pat…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: The Value of add-on Arrhythmia Surgery in Patients With Atrial Fibrillation Undergoing Cardiac Surgery [NA]
This clinical trial evaluated the value of adding arrhythmia surgery for patients with atrial fibrillation undergoing cardiac surgery, and t…
-
FDA approval · 2009-11-20FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited.
-
CLINICAL_TRIALS research · 2009-11-18Clinical Trial Update: Efficiency of Radiofrequency Ablation for Surgical Treatment of Chronic Atrial Fibrillation With Rheumatic Valve Disease [Phase 3]
This is a Phase 3 clinical trial update. It investigates the efficiency of radiofrequency ablation as a surgical treatment for chronic atria…
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation [Phase 3]
A Phase 3 trial compared dronedarone to amiodarone for maintaining sinus rhythm in patients with atrial fibrillation, reporting efficacy and…